Nurse Practitioner · Orange City, FL
NPI
1730698044
Since 2017
Specialty
Nurse Practitioner
Code 363L00000X
Group practices
3
Medicare group memberships
Hospitals
5
Hospital affiliations
1061 Medical Center Dr Ste 305
Orange City, FL, 32763
Phone (386) 943-3190
Groups this clinician bills Medicare through
Medicare paid, 2022
$9,686
188 services
Medicare patients, 2022
89
Average age 67
Drug cost, 2024
$2.1M
1,981 prescriptions
Company payments, 2025
$4,134
From 27 companies
Procedures and visits billed to Original Medicare, 2022
In 2022, the most common Medicare service billed by Michael Lagoe was code 99214 (office e&m - established), 95 times for 64 patients. In total Michael Lagoe billed 188 services in 7 codes, and Medicare paid $9,686.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-10-09.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 95 | 64 | $67.20 | $6,384 |
| 99213 Office E&M - Established | Office | 77 | 53 | $27.95 | $2,152 |
Medicare prescription drug claims, 2024
In 2024, the drug Michael Lagoe prescribed most often to Medicare patients was Carbidopa-Levodopa (Carbidopa/Levodopa), with 496 prescriptions and refills. In total Michael Lagoe wrote 1,981 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Carbidopa-Levodopa Carbidopa/Levodopa | 496 | 1,235 | 176 | $18K |
| Rytary Carbidopa/Levodopa | 224 | 352 | 53 | $356K |
| Carbidopa-Levodopa Er Carbidopa/Levodopa | 173 | 454 | 62 | $6,905 |
| Memantine Hcl Generic | 96 | 203 | 36 | $3,048 |
| Gocovri Amantadine Hcl | 84 | 126 | 14 | $333K |
| Donepezil Hcl Generic | 68 | 173 | 35 | $705 |
| Gabapentin Generic | 59 | 102 | 19 | $1,067 |
| Memantine Hcl Er Memantine Hcl | 54 | 91 | 12 | $4,479 |
| Pramipexole Dihydrochloride Pramipexole Di-Hcl | 54 | 153 | 18 | $1,336 |
| Rivastigmine Generic | 52 | 72 | 15 | $7,120 |
| Ropinirole Hcl Generic | 44 | 100 | 14 | $640 |
| Nuplazid Pimavanserin Tartrate | 41 | 43 | Under 11 | $217K |
| Amantadine Amantadine Hcl | 37 | 80 | 12 | $2,007 |
| Nurtec Odt Rimegepant Sulfate | 32 | 32 | Under 11 | $52K |
| Primidone Generic | 30 | 78 | 12 | $1,330 |
Brand drugs: 579 claims; generic drugs: 1,402 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Michael Lagoe $4,134 ($4,134 in general payments such as food, travel and fees) from 27 companies. The largest payer was Amneal Pharmaceuticals LLC with $1,120.
| Company | Payments | Amount |
|---|---|---|
| Amneal Pharmaceuticals LLC AMRX | 9 | $1,120 |
| Abbvie Inc. ABBV | 34 | $579 |
| Neurocrine BioSciences, Inc. NBIX | 17 | $371 |
| Pfizer Inc. PFE | 25 | $269 |
| ACADIA Pharmaceuticals Inc ACAD | 16 | $269 |
| Teva Pharmaceuticals USA, Inc. TEVA | 9 | $211 |
| MDD US Operations, LLC | 12 | $177 |
| Biogen, Inc. BIIB | 8 | $148 |
| Lilly USA, LLC LLY | 6 | $124 |
| UCB, Inc. UCB.BR | 4 | $105 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.